GLC DETERMINATION OF PLASMA DRUG LEVELS AFTER ORAL-ADMINISTRATION OF CLORAZEPATE POTASSIUM SALTS

被引：27

作者：

HOFFMAN, DJ ^{[1
]}

CHUN, AHC ^{[1
]}

机构：

[1] ABBOTT LABS,PHARM PROD DIV,CHICAGO,IL 60064

来源：

关键词：

D O I：

10.1002/jps.2600641017

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：1668 / 1671

页数：4

共 9 条

[1] CLORAZEPATE DIPOTASSIUM - NEW BENZODIAZEPINE ANTIANXIETY AGENT [J].

CHARALAMPOUS, KD ;

TOOLEY, W ;

YATES, C .

[2]

LEHMANN M, 1968, CAH MED LYON, V44, P2201

[3]

PLOTNIKOFF NP, 1973, RES COMMUN CHEM PATH, V5, P128

[4] METABOLIC ALTERATION OF DRUGS [J].

SCHREIBER, EC .

ANNUAL REVIEW OF PHARMACOLOGY, 1970, 10 :77-+

[5]

SCHWARTZ MA, 1965, J PHARMACOL EXP THER, V149, P423

[6]

SILVA JAF, 1966, J PHARM SCI, V55, P692

[7]

SILVA JAF, 1964, ANAL CHEM, V36, P2099

[8]

WIERSUM J, 1972, CURR THER RES CLIN E, V14, P442

ZINGALES, IA .

JOURNAL OF CHROMATOGRAPHY, 1973, 75 (01) :55-78